Is there accord in ACCORD? Lower blood pressure targets in type 2 diabetes does not lead to fewer cardiovascular events except for reductions in stroke

Journal of Clinical Hypertension

Volumn 12, Issue 7, 2010, Pages 472-477

  Bloch, Michael J ^a,b   Basile, Jan N ^c,d  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b Saint Mary's   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIAZIDE DIURETIC AGENT;

ALBUMINURIA; ATHEROSCLEROSIS; BRADYCARDIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DRUG DOSE TITRATION; DYSLIPIDEMIA; EDITORIAL; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SIDE EFFECT; SMOKING; SYSTOLIC BLOOD PRESSURE; UNSTABLE ANGINA PECTORIS;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK FACTORS; STROKE;

EID: 77955264423     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2010.00333.x     Document Type: Editorial

References (8)

1. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7). Hypertension. 2003, 42:1206.
2. Standards of Medical Care in Diabetes-2010. Diabetes Care. 2010, 33(1):S4. Executive Summary
3. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Eng J Med. 2010, 362(17):1585.
4. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998, 317:703-713.
5. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ. 1998, 317:713-720.
6. Hansson L, Zanchetti A, Carruthers SG. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998, 351:1755-1762.
7. Zanchetti A, Hansson L, Clement D. Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? J Hypertens. 2003, 21:797-804.
8. Gaede P, Vedel P, Parving HH. Intensified multifactoral intervention in patients with type 2 diabetes mellitus and microalbuminuria. Lancet. 1999, 353(9153):617-622.